刘芳勋

主治

北京大学国际医院

1、在意大利，幽门螺杆菌 rRNA的点突变与克拉霉素耐药性相关。

J Med Microbiol.2014 Mar;63(Pt 3):453-7. doi: 10.1099/jmm.0.067942-0. Epub 2013 Dec 16.

Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy.

De Francesco V¹, Zullo A, Giorgio F, Saracino I, Zaccaro C, Hassan C, Ierardi E, Di Leo A, Fiorini G, Castelli V, Lo Re G, Vaira D.

2、幽门螺杆菌对抗生素耐药性问题：一项针对拉美地区的系统评价。

Am J Gastroenterol. 2014 Mar 4. doi: 10.1038/ajg.2014.24. [Epub ahead of print]

The Problem of Helicobacter pylori Resistance to Antibiotics: A Systematic Review in Latin America.

Camargo MC¹, García A², Riquelme A³, Otero W⁴, Camargo CA⁵, Hernandez-García T², Candia R³, Bruce MG⁶, Rabkin CS¹.

3、在对克拉霉素和（或）甲硝唑中-低度耐药区，缩短14天混合疗法至10/12天，仍能维持较高的幽门螺杆菌根除率。

Helicobacter. 2014 Mar 11. doi: 10.1111/hel.12113. [Epub ahead of print]

Feasibility of Shortening 14-day Hybrid Therapy While Maintaining an Excellent Helicobacter pylori Eradication Rate.

Wu JY¹, Hsu PI, Wu DC, Graham DY, Wang WM.

4、利用新一代测序技术发现新的幽门螺杆菌克拉霉素耐药基因突变

J Antimicrob Chemother.2014 Mar 19. [Epub ahead of print]

Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing.

Binh TT¹, Shiota S, Suzuki R, Matsuda M, Trang TT, Kwon DH, Iwatani S, Yamaoka Y.